ACXP Financials

Acurx Pharmaceuticals Inc - Financial statements & key metrics

Stock Price

$2.57

Market Cap

$6.22M

0

EPS

$-8.18

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

-

Gross Profit

-

Operating Income

-

Net Income

$-14.10M

EPS (Diluted)

$-0.87

Balance Sheet Highlights

Total Assets

$3.86M

Total Liabilities

$3.24M

Shareholders Equity

-

Cash & Equivalents

$3.71M

Total Debt

-

Cash Flow Highlights

Operating Cash Flow

$-10.38M

CapEx

-

Free Cash Flow

-

Profitability Metrics

ROE

-2.9%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is ACXP revenue?

View ACXP's income statement for detailed revenue data.

Is ACXP profitable?

ACXP reported a loss of $14.10M in the most recent quarter.

What is ACXP market cap?

ACXP has a market capitalization of $6.22M, making it a small-cap stock.

Does ACXP have debt?

View ACXP's balance sheet for debt information.

What is ACXP cash flow?

Cash flow data is available in the full financial statements.

Explore Categories